European Markets Making Gains after Asia’s Bad Session

Daily Archives August 31, 2020

0

European Markets Making Gains after Asia’s Bad Session

European markets are continuing to trade higher Monday after nearly all Asian indices sustained serious losses.
The CAC-40 in Paris is up 0.5%, while Frankfurt’s DAX index is 0...

Read More
0

Canada Signs 2 More Deals for Coronavirus Vaccines

OTTAWA – Canada reached an agreement in principle on Monday with both Novavax and Johnson & Johnson for millions of doses of their experimental coronavirus vaccines, Prime Minister Justin Trudeau said...

Read More

Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ ...

•  Canadian government to purchase up to 76 million doses of NVX-CoV2373 GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it has reached an agreement in principle with the Government of Canada to supply up to 76 million […]Read More

AIR Worldwide Estimates Insured Losses for Hurricane Laura Will be ...

Boston, Aug. 31, 2020 (GLOBE NEWSWIRE) — Catastrophe risk modeling firm AIR Worldwide estimates that industry insured losses to onshore property resulting from Hurricane Laura’s winds and storm surge will range from USD 4 billion to USD 8 billion. AIR Worldwide is a Verisk (Nasdaq:VRSK) business. “Although comparisons between Laura and Hurricane Rita (2005) have […]Read More

Philips EV300 ventilator supply contract with U.S. Department of ...

August 31, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has received notice from the U.S. Department of Health and Human Services (HHS) of the partial termination of the April 2020 contract to deliver 43,000 bundled EV300 ventilator configurations to HHS through December 2020. Philips will complete the […]Read More

Junshi Biosciences Announces Financial Results for Six Months Ended ...

— Supplemental NDAs for Toripalimab filed — Expanding into infectious disease and collaborating with IMCAS and Lilly for COVID-19 neutralizing antibodies — Dual Listing on the STAR Market SHANGHAI, China, Aug. 30, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of […]Read More